The USFDA approves Glenmark Pharma's Tacrolimus Ointment

The generic version of Leo Pharma AS's Protopic1 Ointment, 0.03%, Tacrolimus Ointment, 0.03%, has been given final approval by the United States Food & Drug Administration (USFDA).

 

Glenmark Pharmaceuticals Inc., USA will sell Tacrolimus Ointment, 0.03%, in the US.

 

Glenmark now has 184 medications in its portfolio that are approved for sale in the US market, and 51 ANDA’s pending approval with the U.S. FDA.

 

The generic version of AstraZeneca's Onglyza1 tablets, Saxagliptin tablets (2.5 mg and 5 mg), was approved by the US Food & Drug Administration (US FDA) earlier this month.

 

Source: Media Reports

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Candlestick Patterns

blog-logo

11 mins read . 03 Oct 2024

Ascending Triangle Pattern - Definition, Tips, Component & How to Trade

  • 0 people read
blog-logo

IPO

blog-logo

5 mins read . 19 Sep 2024

Vision Infra Equipment Solutions Limited IPO

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions